Review of Oxaliplatin Billing at Bayshore Medical Center for the Period January 1 through December 31, 2005

摘要

Oxaliplatin is a chemotherapy drug used to treat colorectal cancer. Outpatient hospitals received transitional pass-through payments for oxaliplatin furnished to Medicare beneficiaries from July 1, 2003, through December 31, 2005. Medicare required hospitals to bill one service unit for each 5 milligrams of oxaliplatin that a beneficiary received. Bayshore Medical Center (Bayshore) is an acute-care hospital in Pasadena, Texas, that has 300 Medicare-certified beds. We reviewed oxaliplatin payments to Bayshore for services provided to Medicare beneficiaries during calendar year (CY) 2005. Our objective was to determine whether Bayshore billed Medicare for oxaliplatin in accordance with Medicare requirements.